Gilde Healthcare raised finance to support its acquisition of MEG Medical Equipment
We have advised Gilde Healthcare Partners B.V. (Gilde Healthcare) on raising acquisition finance to support its investment in MEG Medical Equipment GmbH (MEG), a provider of high-quality medical aids for treatment and prevention of decubitus and other skin damage resulting from extended immobility.
MEG is a combination of two companies: Funke Medical GmbH, Germany, and Deron B.V., Netherlands. Both companies are leading providers of high-quality and specialised medical equipment for the prevention and therapy of decubitus. Their complementary product portfolio includes medical mattresses, beds, and related products. MEG sets new standards in innovation and environmental responsibility within the medical aids sector via a continuously expanding portfolio of sustainable mattresses and smart care solutions.
MEG is well-positioned to enter new market segments and expand into adjacent application areas, with active support from Gilde Healthcare. Through further acquisitions, MEG intends to accelerate its international expansion.
Gilde Healthcare is a thematic investment firm managing over €2.6bn across two fund strategies in healthcare: Private Equity and Venture&Growth. The Private Equity fund of Gilde Healthcare participates in profitable lower mid-market healthcare companies based in north-western Europe. The Venture&Growth fund of Gilde Healthcare invests in fast-growing companies active in digital health, medical technologies (MedTech), and therapeutics, based in Europe and North America.
We are excited to partner with MEG and look forward to supporting the team on the ambitious growth path. We are impressed by MEG’s strong market position, high-quality medical products, as well as commitment to delivering technology-enabled and sustainable solutions. This aligns perfectly with our strategy to invest in companies that drive positive change in healthcare. Together, we will focus on building out the strong market position of MEG. With ongoing consolidation in the market, we see an opportunity to accelerate the international growth of the group. The structured financing package is perfectly aligned with our growth strategy and will further support us, especially on our inorganic growth path. Clearwater, as our exclusive debt adviser, has done an excellent job throughout the intensive financing process.
We are pleased to have advised Gilde Healthcare on raising finance to support their investment in MEG Medical Equipment. The attractive financing package will support Gilde’s ambitious international expansion and buy and build strategy for MEG, building on its strong foundation of specialised medical equipment and commitment to innovation.